--- title: Bloating or Poor Appetite? Don’t Brush It Off — Early Gastrointestinal Cancers Can Be Easy to Miss url: "https://www.yyhmedical.com/en/news/digestive-early-cancer-screening-high-risk-groups-guide" type: Article inLanguage: en-US category: Expert Insights datePublished: 2026-06-06 --- # Bloating or Poor Appetite? Don’t Brush It Off — Early Gastrointestinal Cancers Can Be Easy to Miss > A practical guide to why early gastrointestinal cancers are easy to miss, four common screening approaches, and how high-risk groups are identified for colorectal, gastric, and esophageal cancers. Summary: Early gastrointestinal cancers often cause few or no typical symptoms, and by the time clear discomfort appears, the disease may already be more advanced. This article explains why early gastrointestinal cancers can be difficult to detect and why early-stage disease may still be highly treatable. It compares four commonly used screening approaches — upper and lower GI endoscopy, fecal occult blood testing and stool DNA testing, tumor markers, and imaging — and outlines when each may be useful. Based on the 2025 edition of China’s Guidelines for Cancer Screening in Health Examination Institutions, it also summarizes criteria used to identify people at higher risk of colorectal, gastric, and esophageal cancers, helping readers better understand the value of screening and choose appropriate tests in time. Occasional bloating, abdominal discomfort, or loss of appetite is easy to dismiss as a minor stomach problem. Many people simply take some medication and wait for it to pass. At an annual checkup, some may even skip a digital rectal examination or avoid gastroscopy and colonoscopy because they worry about discomfort, inconvenience, or embarrassment. It is tempting to think that if there is no severe pain or obvious symptom, cancer must be far away. The reality is that many gastrointestinal cancers may not cause clear, typical symptoms until they have already progressed, potentially missing the best window for treatment. According to 2022 cancer data released by China’s National Cancer Center, colorectal cancer, gastric cancer, and esophageal cancer rank among the ten most common cancers in China, placing second, fifth, and seventh respectively. Because early gastrointestinal cancers can be highly silent and may cause few typical symptoms, proactive screening, early detection, and timely evaluation are especially important. **Why Are Early Gastrointestinal Cancers So Easy to Miss?** The digestive tract is a continuous tube running from the mouth to the anus. The esophagus, stomach, and intestines are among the sites where gastrointestinal cancers commonly arise. Outside the mouth and throat, the wall of the digestive tract is generally described in four layers: the mucosa, submucosa, muscular layer, and outer layer. Early gastrointestinal cancer generally refers to cancer that remains confined to the superficial mucosal layer. A simple way to picture it is like damage that has affected only the surface of a wall without penetrating deeply or spreading elsewhere. At this stage, two features are especially important: - Symptoms can be very subtle. Many patients have no specific symptoms at all, or only mild bloating or reduced appetite. These signs can easily be mistaken for gastritis, enteritis, or another common digestive problem — or simply ignored. - Early disease may be highly curable. When the lesion remains localized and the risk of spread is very low, timely, appropriate treatment can lead to excellent outcomes. The article notes that five-year survival can exceed 90% in early-stage disease. If the early window is missed, cancer cells may invade deeper layers, spread, or metastasize, leading to advanced disease. Using gastric cancer as an example, the article notes a cure rate above 90% for early gastric cancer, compared with a five-year survival rate below 10% for advanced gastric cancer — underscoring why early detection and treatment matter. **What Tests Are Used to Screen for Early Gastrointestinal Cancer?** Some people have annual health checks yet still miss early gastrointestinal cancers because the right screening test was not included. Below are four commonly used screening approaches and the roles they may play: **1\. Endoscopy (Gastroscopy and Colonoscopy): The Gold Standard for Early Detection** Endoscopy remains one of the most important tools for detecting early gastrointestinal cancer. Gastroscopy and colonoscopy allow doctors to directly examine the lining of the esophagus, stomach, and bowel. If a suspicious lesion is found, a tissue sample can be taken immediately for pathology to determine whether it is benign or malignant. In selected early lesions, minimally invasive endoscopic removal may also be performed during the same procedure, combining diagnosis and treatment with relatively limited trauma. For people concerned about discomfort, sedation-assisted or anesthesia-supported endoscopy is now widely used. Patients should discuss the available options, suitability, and risks with their medical team rather than avoiding screening solely because of fear of pain. **2\. Fecal Occult Blood Testing and Stool DNA Testing: Convenient Non-Invasive Screening Options** Both are non-invasive screening approaches used for colorectal cancer. Fecal occult blood testing is inexpensive and easy to perform, making it a common first-line screening option. False-positive results can occur, so repeat testing or additional examinations may be needed. Stool DNA testing is another non-invasive option that may offer higher detection accuracy and is increasingly used in colorectal cancer screening. **3\. Tumor Markers: Helpful as Additional Information, but Not Diagnostic on Their Own** Commonly used tumor markers in gastrointestinal cancers include carcinoembryonic antigen (CEA), CA19-9, CA72-4, CA125, and alpha-fetoprotein (AFP). These blood tests can provide supporting information, but they cannot confirm or rule out cancer on their own. An abnormal result does not automatically mean cancer is present, and a normal result cannot fully exclude early-stage disease. Tumor markers must therefore be interpreted together with other tests and cannot replace gastroscopy or colonoscopy. **4\. Imaging: An Important Complement for Deeper Abdominal Organs** For cancers involving deeper abdominal organs, such as the liver or pancreas, ultrasound, CT, and other imaging tests may be used as part of risk assessment or early detection. These examinations complement endoscopy by evaluating areas that cannot be directly visualized through the gastrointestinal tract. **Who Is Considered at Higher Risk for Early Gastrointestinal Cancer?** **Colorectal Cancer** According to the 2025 edition of China’s Guidelines for Cancer Screening in Health Examination Institutions, higher-risk groups for colorectal cancer include people at increased risk of sporadic colorectal cancer and those with hereditary colorectal cancer syndromes. (1) Higher Risk of Sporadic Colorectal Cancer Risk is scored using age, sex, first-degree family history, smoking history, and body mass index (BMI): Age 49 or younger: 0 points; age 50-59: 1 point; age 60 or older: 2 points. Female: 0 points; male: 1 point. History of smoking: 1 point; no smoking history: 0 points. BMI 23 kg/m² or above: 1 point; BMI below 23 kg/m²: 0 points. A first-degree relative with colorectal cancer: 1 point. If one first-degree relative was diagnosed before age 60, or if two first-degree relatives have colorectal cancer: 4 points. No first-degree family history: 0 points. Age 50 or older and never having undergone colonoscopy: 3 points. A total score of 4 or more is considered high risk. (2) Higher Risk of Hereditary Colorectal Cancer This includes people with Lynch syndrome, familial adenomatous polyposis (FAP), and other hereditary colorectal cancer syndromes. **Gastric Cancer** According to the same 2025 guideline, people aged 45 or older are considered at higher risk if they meet any one of the following criteria: Living in an area with a high incidence of gastric cancer. A first-degree relative — such as a parent, child, or sibling — with a history of gastric cancer. A positive urea breath test (UBT), serum Helicobacter pylori (H. pylori) antibody test, or stool H. pylori antigen test. A smoking history totaling six months or more. Heavy alcohol use, a high-salt diet, frequent consumption of pickled foods, or other unhealthy dietary and lifestyle patterns. A history of chronic atrophic gastritis, gastric ulcer, gastric polyps, a gastric remnant after surgery, hypertrophic gastritis, pernicious anemia, or related conditions. **Esophageal Cancer** According to the same 2025 guideline, people aged 45 or older are considered at higher risk if they meet any one of the following criteria: Long-term residence in an area with a high incidence of esophageal cancer. A first-degree relative — such as a parent, child, or sibling — with a history of esophageal cancer. Long-term habits such as consuming very hot foods or drinks, a high-salt diet, frequent pickled foods, a smoking history totaling six months or more, or heavy alcohol use. A history of chronic esophagitis, Barrett’s esophagus, esophageal diverticulum, achalasia, reflux esophagitis, or benign esophageal stricture. A history of diagnosis or treatment for precancerous esophageal lesions, including esophageal squamous dysplasia or Barrett’s esophagus-associated dysplasia. Gastrointestinal cancer is not something to panic about — but delaying evaluation or avoiding screening can allow an early, more treatable disease to go unnoticed. Pay attention to persistent digestive symptoms, understand your personal risk, and complete appropriate screening when recommended. Early detection, accurate diagnosis, and timely treatment can make a meaningful difference. --- Original (HTML):https://www.yyhmedical.com/en/news/digestive-early-cancer-screening-high-risk-groups-guide This is a clean Markdown mirror for large language models; the original page is authoritative.